Osimertinib compared docetaxel-bevacizumab as third-line treatment in EGFR T790M mutated non-small-cell lung cancer - Concepedia

Concepedia

Publication | Closed Access

Osimertinib compared docetaxel-bevacizumab as third-line treatment in EGFR T790M mutated non-small-cell lung cancer

50

Citations

22

References

2018

Year

Keke Nie, Zhongfa Zhang, Chunling Zhang, Chuanxin Geng, Ling Zhang, Xiajuan Xu, Shichao Liu, Songping Wang, Xingjun Zhuang, Ketao Lan,

Egfr T790mNon-small-cell Lung CancerMedicinePathologyBronchial NeoplasmCancer TreatmentCancer GeneticsThird-line TreatmentOncologyLung CancerMolecular Oncology

References

	Year	Citations

Page 1

Page 1